T1	p 70 74	cows
T2	p 170 174	cows
T3	p 354 362	patients
T4	p 368 370	C.
T5	p 644 648	cows
T6	p 714 721	protein
T7	p 797 813	77 patients with
T8	p 1100 1109	with CDAD
T9	p 1207 1228	individuals with CDAD
T10	i 20 44	whey protein concentrate
T11	i 119 157	whey protein concentrate prepared from
T12	i 262 283	, toxin A and toxin B
T13	i 464 522	anti-C. difficile whey protein concentrate ( anti-CD WPC )
T14	i 682 685	WPC
T15	i 698 735	of regular whey protein concentrate .
T16	i 858 869	anti-CD WPC
T17	i 1065 1068	WPC
T18	i 1176 1187	anti-CD WPC
T19	o 93 104	Clostridium
T20	o 208 219	Clostridium
T21	o 235 244	difficile
T22	o 255 261	toxins
T23	o 264 281	toxin A and toxin
T24	o 392 407	diarrhea ( CDAD
T25	o 423 430	relapse
T26	o 438 449	infection .
T27	o 454 481	safety of anti-C. difficile
T28	o 581 597	of raw milk from
T29	o 659 670	composition
T30	o 822 833	demonstrate
T31	o 881 888	relapse
T32	o 936 960	adverse event monitoring
T33	o 972 984	examinations
T34	o 1001 1014	hematological
T35	o 1019 1042	biochemical assessments
T36	o 1191 1195	safe
T37	o 1229 1230	,